Mark Belger

2.5k total citations
83 papers, 1.7k citations indexed

About

Mark Belger is a scholar working on Psychiatry and Mental health, Economics and Econometrics and General Health Professions. According to data from OpenAlex, Mark Belger has authored 83 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Psychiatry and Mental health, 32 papers in Economics and Econometrics and 13 papers in General Health Professions. Recurrent topics in Mark Belger's work include Health Systems, Economic Evaluations, Quality of Life (32 papers), Dementia and Cognitive Impairment Research (23 papers) and Sexual function and dysfunction studies (8 papers). Mark Belger is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (32 papers), Dementia and Cognitive Impairment Research (23 papers) and Sexual function and dysfunction studies (8 papers). Mark Belger collaborates with scholars based in United Kingdom, United States and Germany. Mark Belger's co-authors include Catherine Reed, Josep María Haro, Roy Jones, Richard Dodel, Anders Wimo, Bruno Vellas, Giuseppe Bruno, Rachel Johnson, Peter J. Morris and Susan V. Fuggle and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Statistics in Medicine.

In The Last Decade

Mark Belger

81 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Belger United Kingdom	22	764	338	321	238	204	83	1.7k
Jean‐Luc Novella France	28	731 1.0×	410 1.2×	677 2.1×	141 0.6×	128 0.6×	126	2.3k
Heather McDonald Canada	15	538 0.7×	457 1.4×	454 1.4×	232 1.0×	153 0.8×	16	3.1k
Brittany Lapin United States	30	265 0.3×	182 0.5×	309 1.0×	985 4.1×	101 0.5×	184	3.1k
Valeria Saglimbene Australia	25	438 0.6×	118 0.3×	160 0.5×	232 1.0×	257 1.3×	51	2.2k
Olalekan Lee Aiyegbusi United Kingdom	19	190 0.2×	317 0.9×	360 1.1×	103 0.4×	331 1.6×	81	1.9k
Chiun‐Fang Chiou United States	26	501 0.7×	573 1.7×	333 1.0×	257 1.1×	171 0.8×	45	3.0k
Bradley Dain United States	16	296 0.4×	40 0.1×	249 0.8×	256 1.1×	291 1.4×	37	1.8k
Jarcy Zee United States	27	182 0.2×	79 0.2×	135 0.4×	260 1.1×	66 0.3×	95	2.0k
Paul J. Hauptman United States	24	112 0.1×	160 0.5×	296 0.9×	463 1.9×	67 0.3×	57	2.4k
Olivier Guérin France	26	379 0.5×	76 0.2×	153 0.5×	222 0.9×	55 0.3×	114	2.2k

Countries citing papers authored by Mark Belger

Since Specialization

Citations

This map shows the geographic impact of Mark Belger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Belger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Belger more than expected).

Fields of papers citing papers by Mark Belger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Belger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Belger. The network helps show where Mark Belger may publish in the future.

Co-authorship network of co-authors of Mark Belger

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Belger. A scholar is included among the top collaborators of Mark Belger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Belger. Mark Belger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boustani, Malaz, Erin Doty, Louis P. Garrison, et al.. (2024). Estimating the Economically Justifiable Price of Limited-Duration Treatment with Donanemab for Early Symptomatic Alzheimer’s Disease in the United States. Neurology and Therapy. 13(6). 1641–1659. 2 indexed citations

Choong, Casey, Mark Belger, Alisa E. Koch, et al.. (2022). Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States. Advances in Therapy. 39(10). 4723–4741.

Belger, Mark, et al.. (2022). Relative efficacy of lasmiditan versus rimegepant and ubrogepant as acute treatments for migraine: network meta-analysis findings. The Journal of Headache and Pain. 23(1). 76–76. 16 indexed citations

Ohsfeldt, Robert L., et al.. (2021). Cost-Effectiveness of Baricitinib Compared With Standard of Care: A Modeling Study in Hospitalized Patients With COVID-19 in the United States. Clinical Therapeutics. 43(11). 1877–1893.e4. 10 indexed citations

Petto, Helmut, Zbigniew Kadziola, Alan Brnabic, Daniel Saure, & Mark Belger. (2018). Alternative Weighting Approaches for Anchored Matching-Adjusted Indirect Comparisons via a Common Comparator. Value in Health. 22(1). 85–91. 24 indexed citations

Dell’Agnello, Grazia, Urvi Desai, Noam Y. Kirson, et al.. (2018). Reliability of coded data to identify earliest indications of cognitive decline, cognitive evaluation and Alzheimer’s disease diagnosis: a pilot study in England. BMJ Open. 8(3). e019684–e019684. 6 indexed citations

Lenox‐Smith, Alan, Catherine Reed, Jérémie Lebrec, Mark Belger, & Roy Jones. (2018). Potential cost savings to be made by slowing cognitive decline in mild Alzheimer’s disease dementia using a model derived from the UK GERAS observational study. BMC Geriatrics. 18(1). 57–57. 21 indexed citations

Nordon, Clémentine, Hélène Verdoux, Josep María Haro, et al.. (2017). The use of random-effects models to identify health care center-related characteristics modifying the effect of antipsychotic drugs. Clinical Epidemiology. Volume 9. 689–698. 3 indexed citations

Efthimiou, Orestis, Dimitris Mavridis, Thomas P. A. Debray, et al.. (2017). Combining randomized and non‐randomized evidence in network meta‐analysis. Statistics in Medicine. 36(8). 1210–1226. 130 indexed citations

10.

Mühlbacher, Axel, F. Reed Johnson, Jui‐Chen Yang, Michael Happich, & Mark Belger. (2016). Do You Want to Hear the Bad News? The Value of Diagnostic Tests for Alzheimer’s Disease. Value in Health. 19(1). 66–74. 20 indexed citations

11.

Belger, Mark, et al.. (2015). Comparing Resource Use In Alzheimer’s Disease Across Three European Countries - 18-Month Results of The Geras Study. Value in Health. 18(7). A759–A760. 4 indexed citations

12.

Belger, Mark, Alan Brnabic, Zbigniew Kadziola, Helmut Petto, & D Faries. (2015). Alternative Weighting Approaches For Matching Adjusted Indirect Comparisons (Maic). Value in Health. 18(3). A31–A32. 6 indexed citations

13.

Girman, Cynthia J., Douglas E. Faries, Patrick Ryan, et al.. (2014). Pre-study feasibility and identifying sensitivity analyses for protocol pre-specification in comparative effectiveness research. Journal of Comparative Effectiveness Research. 3(3). 259–270. 17 indexed citations

14.

Reed, Catherine, Mark Belger, Grazia Dell’Agnello, et al.. (2014). Caregiver Burden in Alzheimer's Disease: Differential Associations in Adult-Child and Spousal Caregivers in the GERAS Observational Study. Dementia and Geriatric Cognitive Disorders Extra. 4(1). 51–64. 89 indexed citations

15.

Ferrières, Jean, et al.. (2011). A prospective observational study of treatment practice patterns in acute coronary syndrome patients undergoing percutaneous coronary intervention in Europe. Archives of cardiovascular diseases. 104(2). 104–114. 8 indexed citations

16.

Bakhai, Ameet, Andrés Íñiguez, Jean Ferrières, et al.. (2011). Treatment patterns in acute coronary syndrome patients in the United Kingdom undergoing PCI. EuroIntervention. 6(8). 992–996. 5 indexed citations

17.

Bakhai, Ameet, Jean Ferrières, Andrés Íñiguez, et al.. (2011). International data on supportive therapies at 1 year in acute coronary syndrome patients undergoing PCI: results from the APTOR study. European Journal of Cardiovascular Prevention & Rehabilitation. 18(3). 518–525. 7 indexed citations

18.

Ferrières, Jean, Ameet Bakhai, Andrés Íñiguez, et al.. (2010). Treatment patterns in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Current Medical Research and Opinion. 26(9). 2193–2202. 9 indexed citations

19.

Johnson, Rachel, Mark Belger, J. D. Briggs, S Fuggle, & P J Morris. (2000). Renal transplantation in the UK and Republic of Ireland.. PubMed. 105–13. 2 indexed citations

20.

Fuggle, S, et al.. (1998). A new national allocation scheme for adult kidneys in the United Kingdom. United Kingdom Transplant Support Service Authority (UKTSSA) Users' Kidney Advisory Group and its Task Forces.. PubMed. 107–13. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact